ClearBridge Investments
CGON icon

ClearBridge Investments’s CG Oncology CGON Stock Holding History

ClearBridge Investments’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.3M Buy
735,736
+5,453
+0.7% +$356K 0.04% 323
2026
Q1 		$49.4M Buy
730,283
+25,269
+4% +$1.43M 0.04% 311
2025
Q4 		$29.3M Buy
705,014
+91,162
+15% +$3.77M 0.02% 396
2025
Q3 		$24.7M Buy
+613,852
New +$17.8M 0.02% 421

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments's CGON Position: Q2 2026 in Review

ClearBridge Investments increased its CG Oncology (CGON) stake by 0.75% in Q2 2026, buying an estimated $356K and bringing the position to 735,736 shares worth $52.3M. The position accounts for 0.04% of the portfolio, ranked #323.

ClearBridge Investments first reported a position in CGON in Q3 2025 and has held it in 4 quarters since. 226 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • ClearBridge Investments held 735,736 shares of CG Oncology worth $52.3M as of Q2 2026.
  • ClearBridge Investments bought 5,453 CG Oncology shares in Q2 2026, an estimated $356K.
  • CG Oncology made up 0.04% of ClearBridge Investments's portfolio in Q2 2026, its #323 holding.
  • ClearBridge Investments first reported a position in CG Oncology in Q3 2025 and has held it in 4 quarters since.
  • 226 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.